Test-Retest of MR Fingerprinting technology for improved visualization and quantification of tissue and organs in healthy volunteers and brain tumor patients

Test-Retest of MR Fingerprinting technology for improved visualization and quantification of tissue and organs in healthy volunteers and brain tumor patients - MR Fingerprintig Sequences Validation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48926

Enrollment

Registered

2018-05-18

Start date

2019-01-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tissues and organs

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: - Healthy subject (defined as a volunteer who is not referred to Erasmus MC with signs and symptoms of disease) - At least 18 years old and not older than 50 years old. - Signed informed consent Patients: - Patients with brain tumor with previous conventional scan and referred to conventional treatment. - Adults - Signed informed consent

Exclusion criteria

Exclusion criteria: Healthy subjects: - Subjects with a typical contra-indication to an MRI exam. - Subjects with metal implants. - Woman who are pregnant or lactating - Having any physical or mental status that interferes with the informed consent procedure Patients: - Subjects with a typical contra-indication to an MRI exam. - Subjects with metal implants. - Woman who are pregnant or lactating - Having any physical or mental status that interferes with the informed consent procedure

Design outcomes

Primary

Measure	Time frame
Healthy volunteers: Parameters of image quality: artefacts, signal to noise, contrast to noise, reproducibility, accuracy. Patients: Quantitative MR (T1, T2, PD).	—

Countries

Netherlands

Outcome results